Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma

As a clinical setting in which novel treatment options are urgently needed, hepatocellular carcinoma (HCC) exhibits intriguing opportunities for oncolytic virotherapy. Here we report the rational generation of a novel herpes simplex virus type 1 (HSV-1)-based oncolytic vector for targeting HCC, name...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yong, Lin, Chaolong, Ren, Wenfeng, Ju, Fei, Xu, Zilong, Liu, Huiling, Yu, Zeng, Chen, Jun, Zhang, Jun, Liu, Pingguo, Huang, Chenghao, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838930/
https://www.ncbi.nlm.nih.gov/pubmed/31720372
http://dx.doi.org/10.1016/j.omto.2019.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838930/
https://www.ncbi.nlm.nih.gov/pubmed/31720372
http://dx.doi.org/10.1016/j.omto.2019.09.004

Ejemplares similares